Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Holt

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Nature Biotechnology|March 11, 2008
Synthetic genomes brought closer to lifeRobert A Holt
Genome Medicine|November 20, 2015
Immunogenomics: a foundation for intelligent immune designRobert A Holt
Cell Host & Microbe|January 12, 2023
Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomesRobert A Holt
Nature Biotechnology|September 13, 2017
Interpreting the T-cell receptor repertoireRobert A Holt
Gastroenterology|February 2, 2017
Tumor Potentiating Mechanisms of Fusobacterium nucleatum, A Multifaceted MicrobeRobert A Holt, Kyla Cochrane
Human Immunology|April 24, 2014
T-cell epitope discovery technologiesGovinda Sharma, Robert A Holt
Plos One|May 19, 2011
Targeted assembly of short sequence readsRené L Warren, Robert A Holt
Oncoimmunology|February 7, 2019
Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidomeScott D Brown, Robert A Holt
Human Immunology|December 29, 2009
A census of predicted mutational epitopes suitable for immunologic cancer controlRené L Warren, Robert A Holt
Trends in Molecular Medicine|January 29, 2017
Cell-Based Therapeutics: Making a Faustian Pact with BiologyDaniel J Woodsworth, Robert A Holt
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Nature Biotechnology|March 11, 2008
Synthetic genomes brought closer to lifeRobert A Holt
Genome Medicine|November 20, 2015
Immunogenomics: a foundation for intelligent immune designRobert A Holt
Cell Host & Microbe|January 12, 2023
Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomesRobert A Holt
Nature Biotechnology|September 13, 2017
Interpreting the T-cell receptor repertoireRobert A Holt
Gastroenterology|February 2, 2017
Tumor Potentiating Mechanisms of Fusobacterium nucleatum, A Multifaceted MicrobeRobert A Holt, Kyla Cochrane
Human Immunology|April 24, 2014
T-cell epitope discovery technologiesGovinda Sharma, Robert A Holt
Plos One|May 19, 2011
Targeted assembly of short sequence readsRené L Warren, Robert A Holt
Oncoimmunology|February 7, 2019
Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidomeScott D Brown, Robert A Holt
Human Immunology|December 29, 2009
A census of predicted mutational epitopes suitable for immunologic cancer controlRené L Warren, Robert A Holt
Trends in Molecular Medicine|January 29, 2017
Cell-Based Therapeutics: Making a Faustian Pact with BiologyDaniel J Woodsworth, Robert A Holt
Pageof 14